CONNECTING THE DEFENCE COMMUNITY WITH INSIGHT, INTELLIGENCE & OPPORTUNITIES

Officially Supported By: Defence Contracts International Supply2Defence

Official Media Partners for:

Raytheon is developing a portable device to evaluate bacteria and their potential to cause harm, which could support the future development of medical countermeasures and improved screening tools. Under the DARPA Friend or Foe program, Raytheon is developing biosurveillance technology that detects bacterial pathogens as soon as or before they threaten ...


RELATED ARTICLES

The extension reaffirms Raytheon UK's commitment to providing cutting-edge, technology-enabled solutions to meet the evolving needs of modern military operations.

December 2, 2024

Homeland - Raytheon UK secures two-year extension for Command and Staff Training with British Army

Raytheon UK, part of RTX’s Raytheon business, has secured a two-year extension of its Command and Staff Training contract, continuing

Raytheon was awarded a $677M contract to continue to produce AN/SPY-6(V) radars for the US Navy. This is the third option exercised from the March 2022 hardware, production and sustainment contract that is valued up to $3Bn over five years.

June 20, 2024

Maritime - RTX awarded $677M US Navy contract

Raytheon has been awarded a $677M contract to continue to produce AN/SPY-6(V) radars for the US Navy. This is the